Vertex Growth Fund is a venture capital fund managed by Vertex Holdings, the investment arm of Temasek Holdings. It focuses on growth-stage technology and healthcare companies, primarily in Southeast Asia and the United States. In 2024, Vertex Growth co-led the $50M round for Cala Health alongside Nexus NeuroTech Ventures and J&J, indicating a direct neuromodulation investment. Vertex Growth is most relevant for neurotech companies at Series B and beyond that are scaling commercially.